Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.

ABSTRACT:

Background

Inflammation scores based on general inflammation markers as leucocyte count or C-reactive protein have been evaluated as prognostic markers of inferior survival in several cancers. In small cell lung cancer (SCLC), however, inflammation scores are less studied. In the present study, we set out to perform a systematic review and meta-analysis investigating reported associations between inflammation scores and overall survival (OS) in SCLC.

Methods

A literature search was performed in PubMed, Embase, Scopus, and Web of Science following the Preferred Reporting Items for Systematic and Meta-Analyses (PRISMA) guidelines. Of the identified publications, only studies in English containing original data evaluating inflammation scores as a prognostic factor in SCLC patie

SUBMITTER: Winther-Larsen A 

PROVIDER: S-EPMC7844954 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature